“…Of the four studies included, two showed a benefit in pain and distress with ketamine, while the others demonstrated either no difference between ketamine and fentanyl or ketamine and a placebo. In another meta‐analysis that also included trials we excluded, Lee and Lee included six trials and 438 patients and found ketamine to be either similar or superior to opioids and placebos. Ketamine was associated with a higher rate of neurologic and psychiatric adverse events (respectively, RR = 2.17, 95% CI = 1.37 to 3.42, p < 0.001, NNH = 9; RR = 13.86, 95% CI = 4.85 to 39.58, p < 0.001, NNH = 4), while opioids were associated with a higher risk of major cardiovascular events (RR = 0.22, 95% CI = 0.05–1.01, p = 0.05, NNH = 28), although the clinical significance of this is debatable.…”